{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:41Z","timestamp":1786118741622,"version":"build-2736575974"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/fpc.0b013e32801233fc","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T14:31:52Z","timestamp":1209911512000},"page":"529-538","source":"Crossref","is-referenced-by-count":19,"title":["Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide\/methotrexate\/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer"],"prefix":"10.1097","volume":"17","author":[{"given":"Malgorzata","family":"Jaremko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Justenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny K.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren","family":"Vollmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Illig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiltrud","family":"Brauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210212","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1634\/theoncologist.6-2-133","article-title":"Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond","volume":"6","author":"Esteva","year":"2001","journal-title":"Oncologist"},{"key":"R2-7-20210212","first-page":"930","article-title":"Early Breast Cancer Trialists' Collaborative Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R3-7-20210212","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199810013391407","article-title":"Treatment of breast cancer","volume":"339","author":"Hortobagyi","year":"1998","journal-title":"N Engl J Med"},{"key":"R4-7-20210212","first-page":"1225","article-title":"The pharmacological basis of therapeutics","author":"Calabresi","year":"1996"},{"key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature01408","article-title":"DNA damage and repair","volume":"421","author":"Friedberg","year":"2003","journal-title":"Nature"},{"key":"R6-7-20210212","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1056154","article-title":"Human DNA repair genes","volume":"291","author":"Wood","year":"2001","journal-title":"Science"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/em.1033","article-title":"Human DNA repair genes","volume":"37","author":"Ronen","year":"2001","journal-title":"Environ Mol Mutagen"},{"key":"R8-7-20210212","first-page":"1054","article-title":"Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans","volume":"11","author":"Mohrenweiser","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R9-7-20210212","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer","volume":"94","author":"Bosken","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R11-7-20210212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-200645030-00003","article-title":"Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer","volume":"45","author":"Bosch","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"R12-7-20210212","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","article-title":"Pharmacogenetics of outcome in children with acute lymphoblastic leukemia","volume":"105","author":"Rocha","year":"2005","journal-title":"Blood"},{"key":"R13-7-20210212","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","article-title":"CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment","volume":"97","author":"Jin","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R14-7-20210212","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.tpj.6500242","article-title":"Pharmacogenetics in the treatment of breast cancer","volume":"4","author":"Stearns","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"R15-7-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0921-8777(99)00058-0","article-title":"XRCC1 keeps DNA from getting stranded","volume":"459","author":"Thompson","year":"2000","journal-title":"Mutat Res"},{"key":"R16-7-20210212","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1158\/1078-0432.CCR-04-2657","article-title":"Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients","volume":"11","author":"Chang-Claude","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R17-7-20210212","first-page":"1168","article-title":"Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy","volume":"12","author":"Moullan","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-7-20210212","first-page":"3075","article-title":"A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer","volume":"21","author":"Stoehlmacher","year":"2001","journal-title":"Anticancer Res"},{"key":"R19-7-20210212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc1800","article-title":"Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy","volume":"6","author":"Cheok","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R20-7-20210212","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/humu.20141","article-title":"MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET)","volume":"25","author":"Jaremko","year":"2005","journal-title":"Hum Mutat"},{"key":"R21-7-20210212","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1158\/1055-9965.2059.13.12","article-title":"ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population","volume":"13","author":"Justenhoven","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-7-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R23-7-20210212","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/379378","article-title":"A comparison of bayesian methods for haplotype reconstruction from population genotype data","volume":"73","author":"Stephens","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R24-7-20210212","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1021\/bi962281m","article-title":"XRCC1 protein interacts with one of two distinct forms of DNA ligase III","volume":"36","author":"Nash","year":"1997","journal-title":"Biochemistry"},{"key":"R25-7-20210212","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1002\/j.1460-2075.1996.tb01056.x","article-title":"Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein","volume":"15","author":"Kubota","year":"1996","journal-title":"EMBO J"},{"key":"R26-7-20210212","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1128\/MCB.18.6.3563","article-title":"XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage","volume":"18","author":"Masson","year":"1998","journal-title":"Mol Cell Biol"},{"key":"R27-7-20210212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1096\/fasebj.11.1.9034168","article-title":"A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins","volume":"11","author":"Bork","year":"1997","journal-title":"FASEB J"},{"key":"R28-7-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(96)01312-9","article-title":"From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair","volume":"400","author":"Callebaut","year":"1997","journal-title":"FEBS Lett"},{"key":"R29-7-20210212","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"R30-7-20210212","first-page":"2557","article-title":"XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency","volume":"59","author":"Lunn","year":"1999","journal-title":"Cancer Res"},{"key":"R31-7-20210212","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/carcin\/21.5.965","article-title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells","volume":"21","author":"Duell","year":"2000","journal-title":"Carcinogenesis"},{"key":"R32-7-20210212","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/carcin\/22.6.917","article-title":"Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity","volume":"22","author":"Hu","year":"2001","journal-title":"Carcinogenesis"},{"key":"R33-7-20210212","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/carcin\/bgh064","article-title":"Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA","volume":"25","author":"Vodicka","year":"2004","journal-title":"Carcinogenesis"},{"key":"R34-7-20210212","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1200\/JCO.2005.04.8322","article-title":"Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy","volume":"24","author":"Ruzzo","year":"2006","journal-title":"J Clin Oncol"},{"key":"R35-7-20210212","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO.2005.04.4206","article-title":"Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"R36-7-20210212","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/jnci\/84.19.1512","article-title":"ERCCI and ERCC2 expression in malignant tissues from ovarian cancer patients","volume":"84","author":"Dabholkar","year":"1992","journal-title":"J Nat! Cancer Inst"},{"key":"R37-7-20210212","first-page":"13","article-title":"A nucleotide polymorphism in ERCCI in human ovarian cancer cell lines and tumor tissues","volume":"382","author":"Yu","year":"1997","journal-title":"Muta Res"},{"key":"R38-7-20210212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00001813-200206000-00010","article-title":"DNA repair protein levels vis-a-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program","volume":"13","author":"Xu","year":"2002","journal-title":"Anticancer Drugs"},{"key":"R39-7-20210212","first-page":"7430","article-title":"Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype","volume":"61","author":"Seker","year":"2001","journal-title":"Cancer Res"},{"key":"R40-7-20210212","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"R41-7-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"R42-7-20210212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1019693504183","article-title":"Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer","volume":"75","author":"Tang","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"R43-7-20210212","first-page":"115","article-title":"Polymorphisms in the human DNA repair gene XPF","volume":"406","author":"Fan","year":"1999","journal-title":"Mutat Res"},{"key":"R44-7-20210212","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.20134","article-title":"Reduced levels of XPA, ERCCI and XPF DNA repair proteins in testis tumor cell lines","volume":"110","author":"Welsh","year":"2004","journal-title":"Int J Cancer"},{"key":"R45-7-20210212","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ijc.10870","article-title":"Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk","volume":"103","author":"Kumar","year":"2003","journal-title":"IntJ Cancer"},{"key":"R46-7-20210212","first-page":"305","article-title":"Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray","volume":"14","author":"Sakamoto","year":"2001","journal-title":"Hum Cell"},{"key":"R47-7-20210212","first-page":"1200","article-title":"DNA-repair genetic polymorphisms and breast cancer risk","volume":"12","author":"Smith","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prey"},{"key":"R48-7-20210212","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1289\/ehp.6632","article-title":"Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays","volume":"111","author":"Au","year":"2003","journal-title":"Environ Health Perspect"},{"key":"R49-7-20210212","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/jnci\/djh312","article-title":"The role of BRCAI in the cellular response to chemotherapy","volume":"96","author":"Kennedy","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R50-7-20210212","first-page":"6221","article-title":"BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis","volume":"63","author":"Quinn","year":"2003","journal-title":"Cancer Res"},{"key":"R51-7-20210212","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/1078-0432.CCR-0834-3","article-title":"Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features","volume":"10","author":"Han","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R52-7-20210212","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.bjc.6690801","article-title":"A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients","volume":"81","author":"Huuhtanen","year":"1999","journal-title":"Br J Cancer"},{"key":"R53-7-20210212","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737159.3.5.617","article-title":"E- and A-type cyclins as markers for cancer diagnosis and prognosis","volume":"3","author":"Yasmeen","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"R54-7-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2001.6196","article-title":"Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus","volume":"81","author":"Bae","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R55-7-20210212","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bjc.1996.52","article-title":"Prognostic significance of CCND1 (cyclin Dl) overexpression in primary resected non- small-cell lung cancer","volume":"73","author":"Betticher","year":"1996","journal-title":"Br J Cancer"},{"key":"R56-7-20210212","first-page":"137","article-title":"Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung","volume":"10","author":"Ikehara","year":"2003","journal-title":"Oncol Rep"},{"key":"R57-7-20210212","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1101\/gad.8.14.1627","article-title":"Cyclin DI-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts","volume":"8","author":"Pagano","year":"1994","journal-title":"Genes Dev"},{"key":"R58-7-20210212","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"R59-7-20210212","first-page":"1005","article-title":"Alternate splicing produces a novel cyclin D1 transcript","volume":"11","author":"Betticher","year":"1995","journal-title":"Oncogene"},{"key":"R60-7-20210212","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1128\/MCB.17.12.7248","article-title":"A role for cyclin D3 in the endomitotic cell cycle","volume":"17","author":"Zimmet","year":"1997","journal-title":"Mol Cell Biol"},{"key":"R61-7-20210212","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent and independent pathways","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature"},{"key":"R62-7-20210212","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res"},{"key":"R63-7-20210212","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","article-title":"The codon 72 polymorphic variants of p53 have markedly different apoptotic potential","volume":"33","author":"Dumont","year":"2003","journal-title":"Nat Genet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FPC.0b013e32801233fc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:39:54Z","timestamp":1786034394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200707000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32801233fc","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}